Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the whole genome and exome sequencing market grown in recent years?

The whole genome and exome sequencing market has expanded rapidly, expected to grow from $2.02 billion in 2024 to $2.53 billion in 2025, at a CAGR of 24.8%. The market’s historic growth can be attributed to decreasing sequencing costs, rising cases of genetic disorders, increased clinical applications, expanding genomic data repositories, and advancements in bioinformatics.

How is the whole genome and exome sequencing market size expected to evolve during the forecast period?

The whole genome and exome sequencing market is expected to witness exponential growth, reaching $6.14 billion by 2029 at a CAGR of 24.9%. Growth is attributed to population genomics initiatives, increasing demand for precision medicine, advances in single-cell sequencing, expanding non-invasive prenatal testing (NIPT), and rare disease research applications. Major trends include expanded clinical adoption, rapid sequencing advancements, population-scale genomic studies, AI and ML integration, and growing applications in oncology.

Get your whole genome and exome sequencing market report here!

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which key drivers are propelling the whole genome and exome sequencing market’s growth?

The burgeoning interest in customized medical treatment is predicted to fuel the expansion of the whole genome and exome sequencing market going forward. Customized medicine refers to the medical care practice that customizes healthcare decisions and actions to the particularities of every patient, taking into account aspects like genetics, environment, and way of life. Whole genome and exome sequencing aids in customized medicine by providing an all-encompassing examination of a person’s genetic structure. This allows health care decisions and actions to be customized based on their distinct genetic, environmental, and lifestyle factors. For instance, the Personalized Medicine Coalition (PMC), a US-based entity that encourages the comprehension and adoption of personalized medicine, projected in October 2022 that in excess of 75,000 genetic testing products and 300 personalized medicines will grace the market in 2022. Moreover, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, nearly 34%, amounting to 12, fall under the personalized category. As a consequence, the growing demand for personalized medicine is acting as a catalyst for the growth of the whole genome and exome sequencing market.

What are the market segments in the whole genome and exome sequencing industry?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which leading companies are shaping the growth of the whole genome and exome sequencing market?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What key trends are currently impacting the whole genome and exome sequencing market’s development?

Leading companies in the whole genome and exome sequencing markets are shifting their efforts to create cutting-edge technological systems, like ultra-fast NGS (next-generation sequencing) analysis, to stand out in the market. This new technology allows the processing of next-generation sequencing (NGS) data at an unprecedented pace, drastically cutting down on the time needed for genomic data analysis. To demonstrate, in January 2023, QIAGEN Digital Insights (QDI), a bioinformatics firm in the US, unveiled their ultra-fast NGS analysis platform. This platform boasts capabilities such as completing a whole genome process in 25 minutes at a cloud computing cost of $1, thus encouraging efficiency, cost-effectiveness, and scalability. This technological breakthrough significantly improves the speed and availability of genomic data analysis, making it particularly valuable in the whole genome and exome sequencing market by facilitating prompt decision-making and broader implementation of personalized medicine.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

Which geographic areas are influencing the growth of the whole genome and exome sequencing market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Prenatal DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: